Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

After years of medical issues, columnist G Shellye Horowitz has acquired numerous assistive devices, which come in handy ...

With AJ Johnson, they acquired a young prospect with great intangibles, who can defend, and shoot from three. He's 6'4 and only 20 years old so if they harness his potential, they would have found ...

Approved in 2022 by the FDA, Hemgenix is the first gene therapy for the treatment of adults with hemophilia B who currently use factor IX prophylaxis therapy, have current or historical life ...

And now as he's having his worst season as a pro, he's become a member of the Bucks. The Bucks acquired Porter in a trade with the Los Angeles Clippers, a team he joined this season, on Thursday ...

Irish-founded strategic communications and public affairs agency Red Flag Global has been acquired by Ankura Consulting Group. The terms of the deal have not been disclosed but it is understood to ...

U.K.-based sales company Impronta Films has taken global rights to “Canone Effimero,” the latest work by Italy’s twin directorial duo Gianluca and Massimiliano De Serio, ahead of the ...

Informal institutional guidelines restricted the use of factor VIIa (recombinant) to patients with hemophilia A or B with inhibitors, patients with autoimmune antibodies to factor VIII ...

Ocrevus generated sales of $6.7 billion, up 9%. Sales of hemophilia A drug Hemlibra surged 12% year over year to CHF 4.5 billion. Vabysmo sales skyrocketed 68% to CHF 3.9 billion on strong demand ...